2014
DOI: 10.1007/s00432-014-1747-7
|View full text |Cite
|
Sign up to set email alerts
|

Keeping those telomeres short! an innovative intratumoral long-term drug delivery system

Abstract: The results suggest that the direct intratumoral insertion of a PdTMPyP4-containing polymeric rod would be of benefit as an adjuvant treatment for patients undergoing chemo- or radiotherapy. By preventing the lengthening of telomeres and therefore the unrestricted growth of cancer cells, our DDS will provide a significant therapeutic advantage to these treatments without affecting normal tissues.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 64 publications
(71 reference statements)
0
2
0
Order By: Relevance
“…An optimal drug delivery system should maintain the activity and stability of drug molecules through protecting them against degradation, prolonging circulation in vivo, targeting to the site to reduce toxicity to normal cells, controlling drug release, and freely eliminating out of the body. Researchers have developed a series of drug delivery systems, including natural systems like viruses, 10 collagen, and albumin, 11 synthetic polymer systems like liposomes, 12 poly-(lactic-co-glycolic) acid (PLGA), 13 polylactic acid (PLA), 14 oligo(p-phenylenevinylene) (OPV), 15 and poly(p-phenylenevinylene) (PPV), 16 and synthetic inorganic systems like nanocarbon materials 17 and gold nanoparticles. 18 These drug delivery systems increase the drug loading efficiency and minimize the side effects in normal cells.…”
Section: Introductionmentioning
confidence: 99%
“…An optimal drug delivery system should maintain the activity and stability of drug molecules through protecting them against degradation, prolonging circulation in vivo, targeting to the site to reduce toxicity to normal cells, controlling drug release, and freely eliminating out of the body. Researchers have developed a series of drug delivery systems, including natural systems like viruses, 10 collagen, and albumin, 11 synthetic polymer systems like liposomes, 12 poly-(lactic-co-glycolic) acid (PLGA), 13 polylactic acid (PLA), 14 oligo(p-phenylenevinylene) (OPV), 15 and poly(p-phenylenevinylene) (PPV), 16 and synthetic inorganic systems like nanocarbon materials 17 and gold nanoparticles. 18 These drug delivery systems increase the drug loading efficiency and minimize the side effects in normal cells.…”
Section: Introductionmentioning
confidence: 99%
“…5 To overcome these constraints, researchers have focused on exploiting cytocompatible and resorbable biomaterials that possess better interaction with biological systems. 6 Preparation of synthetic polymers occurs in laboratories through chemical reaction; examples include poly(lactic-co-glycolic) acid (PLGA), 7 polylactic acid (PLA), 8 poly-ε-caprolactone (PCL), 8 etc. The challenging concerns such as biocompatibility, tunable biodegradability in relation with the neo-tissue formation after implantation, ease in processability, and controlling the porosity limit the utility of most of these synthetic polymers.…”
Section: Introductionmentioning
confidence: 99%